AnalystsRudy Li
Rudy Li's Stock Forecasts

Analyst Ranking
Top 3%
#115 out of 5301 analysts
Average Return
+101.61%
Win Rate
79%30 out of 38
Risk vs Reward
Poor
Good

Rudy Li's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Praxis Precision Medicines IncPRAX
+787.56%$38.09$338.07
2025-05-07 -
2026-05-06
Strong Buy
Alto Neuroscience IncANRO
+443.39%$4.01$21.79
2025-09-29 -
2026-06-17
Strong Buy
Praxis Precision Medicines IncPRAX
+382.51%$55.96$270.01
2025-07-29 -
2026-06-17
Strong Buy
Stoke Therapeutics IncSTOK
+275.54%$8.26$31.02
2025-03-19 -
2026-03-18
Strong Buy
Definium Therapeutics IncDFTX
+258.54%$6.15$22.05
2025-05-09 -
2026-05-08
Strong Buy

Rudy Li's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Centessa Pharmaceuticals PLCCNTA
5Buy$40.00+0.33%Initiates Coverage On
4 months ago
Alkermes PLCALKS
1Buy$45.00+1.10%Initiates Coverage On
4 months ago
Axsome Therapeutics IncAXSM
1Buy$230.00-8.79%Initiates Coverage On
4 months ago
Xenon Pharmaceuticals IncXENE
5Buy$60.00+12.78%Initiates Coverage On
4 months ago
Stoke Therapeutics IncSTOK
5Buy$40.00+32.19%Initiates Coverage On
4 months ago
Praxis Precision Medicines IncPRAX
4Buy$500.00+85.18%Initiates Coverage On
4 months ago
Neurocrine Biosciences IncNBIX
1Buy$160.00+0.63%Initiates Coverage On
4 months ago
Definium Therapeutics IncDFTX
5Buy$25.00+2.33%Initiates Coverage On
4 months ago
Acadia Pharmaceuticals IncACAD
1Buy$33.00+52.78%Initiates Coverage On
4 months ago
Bright Minds Biosciences IncDRUG
3Strong Buy$80.00N/AMaintains
6 months ago
Immunic IncIMUX
1Strong Buy$30.00+111.27%Initiates Coverage On
9 months ago
Alto Neuroscience IncANRO
1Strong Buy$15.00-31.16%Initiates Coverage On
9 months ago
Reviva Pharmaceuticals Holdings IncRVPH
1Strong Buy$40.00+12,021.21%Initiates Coverage On
9 months ago
Prothena Corp Public Ltd CoPRTA
7Strong Buy$18.00+112.01%Maintains
10 months ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.